Expedeon AG: Expedeon AG raises adjusted EBITDA guidance for 2019 (news with additional features)
DGAP-News: Expedeon AG
/ Key word(s): Change in Forecast
Expedeon AG raises adjusted EBITDA guidance for 2019
Heidelberg, Germany and Cambridge, UK, 29 October 2019 - Expedeon AG (Frankfurt: EXNN; ISIN: DE000A2YN801; Prime Standard) announced today that the Company revised its guidance for the financial year 2019.
With the third quarter 2019, Expedeon AG is expected to reach its full year adjusted EBITDA guidance for 2019 and accordingly raises its full year guidance to EUR 2.5 to 3.0 million (previous guidance: over EUR 2 million). In addition, the Company continues to expect double digit revenue growth for the year.
The revised adjusted EBITDA guidance results in a year-to-year adjusted EBITDA increase of 150 % to 200 % in comparison with the full year 2018 (adjusted EBITDA: EUR 1.0 million).
A definition and explanation of the performance measure adjusted EBITDA can be found on page 27 of the annual report 2018, which is published on the Company's investors' website and accessible at https://investors.expedeon.com/wp-content/uploads/2019/04/Ansicht_4827_2019_Expedeon_Geschaeftsbericht_03_2019_en.pdf.
"Being able to raise our adjusted EBITDA guidance for the full year 2019 underlines the strong operative performance of Expedeon AG in the course of 2019. We were able to benefit from strong organic growth of our immunology and proteomics platform and several successful closed partnerships. Scale effects through the continuous execution of our Grow, Buy & Build strategy during the previous years contributed to this success," said Dr. Heikki Lanckriet, CEO of Expedeon. "We are looking forward to continuing our successful corporate development in 2019 and beyond."
For further information, please contact:
MC Services AG (Investor Relations and International Media Relations)
About Expedeon AG: www.expedeon.com
### This publication is intended for information only and constitutes neither an offer to sell nor an invitation to buy securities. Some statements included in this press release, relating neither to proven financial results nor other historical data, should be viewed as forward-looking, i.e. not definite. Such statements are mainly predictions of future results, trends, plans or goals. These statements should not be considered to be total guarantees since given their very nature they are subject to known and unknown risks and imponderability and can be affected by other factors as a consequence of which the actual results, plans and goals of Expedeon AG may deviate greatly from the established conclusions or implied predictions contained in such statements. Expedeon does not undertake to publicly update or revise these statements in the light of new information or future results or for any other reason. ###
Document title: Guidance_Eng
29.10.2019 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
|Waldhofer Str. 102|
|Phone:||+49 (0) 6221 3540 125|
|Fax:||+49 (0) 6221 3540 127|
|Listed:||Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange|
|EQS News ID:||899453|
|End of News||DGAP News Service|